Legal & General Group
LAB icon

Legal & General Group’s Standard BioTools LAB Stock Holding History

Legal & General Group’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$147K Sell
159,541
-132,375
-45% -$160K ﹤0.01% 2573
2025
Q4 		$374K Hold
291,916
– – ﹤0.01% 2492
2025
Q3 		$379K Sell
291,916
-18,519
-6% -$24.3K ﹤0.01% 2517
2025
Q2 		$373K Buy
310,435
+63,484
+26% +$70.4K ﹤0.01% 2520
2025
Q1 		$267K Hold
246,951
– – ﹤0.01% 2568
2024
Q4 		$432K Hold
246,951
– – ﹤0.01% 2511
2024
Q3 		$477K Sell
246,951
-252
-0.1% -$493 ﹤0.01% 2481
2024
Q2 		$438K Buy
247,203
+54,436
+28% +$133K ﹤0.01% 2462
2024
Q1 		$522K Buy
+192,767
New +$465K ﹤0.01% 2407
2022
Q4 		– Sell
-1,061
Closed -$1K – 3429
2022
Q3 		$1K Sell
1,061
-58,212
-98% -$88K ﹤0.01% 3448
2022
Q2 		$95K Buy
59,273
+32,258
+119% +$79.8K ﹤0.01% 2867
2022
Q1 		$97K Hold
27,015
– – ﹤0.01% 2878
2021
Q4 		$106K Hold
27,015
– – ﹤0.01% 2899
2021
Q3 		$178K Buy
27,015
+14,362
+114% +$94.5K ﹤0.01% 2726
2021
Q2 		$78K Sell
12,653
-407
-3% -$2.18K ﹤0.01% 2808
2021
Q1 		$59K Sell
13,060
-1,865
-12% -$10.2K ﹤0.01% 2767
2020
Q4 		$90K Buy
14,925
+6,944
+87% +$45.6K ﹤0.01% 2614
2020
Q3 		$59K Sell
7,981
-2,898
-27% -$20K ﹤0.01% 2634
2020
Q2 		$43K Sell
10,879
-4,699
-30% -$16.4K ﹤0.01% 2764
2020
Q1 		$40K Sell
15,578
-10,897
-41% -$35.8K ﹤0.01% 2672
2019
Q4 		$91K Buy
26,475
+7,104
+37% +$25K ﹤0.01% 2620
2019
Q3 		$89K Buy
19,371
+4,086
+27% +$32.2K ﹤0.01% 2560
2019
Q2 		$189K Buy
15,285
+9,905
+184% +$126K ﹤0.01% 2361
2019
Q1 		$72K Buy
5,380
+940
+21% +$9.91K ﹤0.01% 2601
2018
Q4 		$38K Buy
4,440
+816
+23% +$6.36K ﹤0.01% 2793
2018
Q3 		$27K Hold
3,624
– – ﹤0.01% 3081
2018
Q2 		$22K Sell
3,624
-3,205
-47% -$18.3K ﹤0.01% 3153
2018
Q1 		$40K Sell
6,829
-2,742
-29% -$18K ﹤0.01% 2854
2017
Q4 		$57K Buy
9,571
+790
+9% +$4.32K ﹤0.01% 2830
2017
Q3 		$45K Hold
8,781
– – ﹤0.01% 2939
2017
Q2 		$36K Hold
8,781
– – ﹤0.01% 2989
2017
Q1 		$49K Sell
8,781
-357
-4% -$2.26K ﹤0.01% 2874
2016
Q4 		$67K Buy
9,138
+4,767
+109% +$29.9K ﹤0.01% 2782
2016
Q3 		$36K Hold
4,371
– – ﹤0.01% 2667
2016
Q2 		$39K Hold
4,371
– – ﹤0.01% 2597
2016
Q1 		$36K Hold
4,371
– – ﹤0.01% 2544
2015
Q4 		$47K Hold
4,371
– – ﹤0.01% 2487
2015
Q3 		$36K Hold
4,371
– – ﹤0.01% 2597
2015
Q2 		$105K Hold
4,371
– – ﹤0.01% 2076
2015
Q1 		$185K Hold
4,371
– – ﹤0.01% 1714
2014
Q4 		$146K Sell
4,371
-292
-6% -$8.27K ﹤0.01% 1745
2014
Q3 		$118K Buy
+4,663
New +$131K ﹤0.01% 1793

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Legal & General Group's LAB Position: Q1 2026 in Review

Legal & General Group reduced its Standard BioTools (LAB) stake by 45% in Q1 2026, selling an estimated $160K and leaving 159,541 shares worth $147K. The position accounts for ﹤0.01% of the portfolio, ranked #2573.

Legal & General Group first reported a position in LAB in Q3 2014 and has held it in 42 quarters since. The position peaked at $522K in Q1 2024. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • Legal & General Group held 159,541 shares of Standard BioTools worth $147K as of Q1 2026.
  • Legal & General Group sold 132,375 Standard BioTools shares in Q1 2026, an estimated $160K.
  • Standard BioTools made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2573 holding.
  • Legal & General Group first reported a position in Standard BioTools in Q3 2014 and has held it in 42 quarters since.
  • Legal & General Group's Standard BioTools position peaked at $522K in Q1 2024.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.